PrescribedRX review
The short answer: PrescribedRX offers three-month compounded GLP-1 plans with payment before clinical review. Confirm the binding denial-refund promise, commitment and pharmacy assignment.
By Leah Fenwick, Provider reviews
These provider links do not earn us a commission. Other links on the site may be affiliate links. How we make money
PrescribedRX by the numbers
- From
- Request a current written quote
- Prescriber
- Confirm the visit format
- Pharmacy
- Name not confirmed
- States
- Confirm availability for your treatment and location
Our take on PrescribedRX
PrescribedRX's current weight-care menu offers compounded semaglutide and tirzepatide injections through a clinical review process. The individual pages identify a three-month plan, included medication, supplies, shipping and portal messaging. They also put eligibility questions and payment before the provider's final prescribing decision. That sequence is useful to understand before starting, especially if you are unsure whether the advertised preparation fits your history. The appointment preparation checklist can organize previous treatment records and questions for the professional reviewing your request. PrescribedRX describes itself as a patient-management and marketing platform rather than the employer of the clinicians or the dispensing pharmacy. Its named care-team biographies do not establish which professional will treat you. Ask for the actual practice and prescriber, how they will contact you if more information is needed and whether your evaluation requires a live encounter. Selecting a plan and paying for it do not guarantee that the provider will issue the prescription. The practical goal is a defined individual treatment plan and a clear explanation of what happens to the payment if the clinical decision differs from the original request.
The GLP-1 product pages state the upfront amount and another charge every three months, alongside a monthly equivalent. That is a quarterly payment arrangement, rather than permission to purchase just one month at the equivalent rate. The commitment worksheet can help compare the amount collected before the next opportunity to reassess. PrescribedRX also advertises the same price across doses and a provider-managed maintenance approach. Ask the clinician what the proposed maintenance plan means for your case, and ask the service which financial terms survive a change of medicine, dose or package. A generalized maintenance promise is not a clinical instruction for every patient. The billing-period guide helps separate a supply description, a monthly equivalent and the actual quarterly card charge. The purchase terms also permit notified price changes and exclude applicable taxes from stated charges. Obtain the selected complete quote and next processing date rather than treating one product display as an unlimited future-price guarantee. If a pause becomes necessary, discuss the clinical decision first and then ask how it affects the active commitment.
The denial-refund promise is prominent and specific. PrescribedRX's product pages and purchase policy say a provider's decision that treatment is inappropriate leads to a full treatment-program refund with no fees deducted. The separate hormone laboratory panel is excluded from that refund, and the weight pages say testing is ordered only if the history calls for it. Do not import the hormone program's payment sequence into the GLP-1 plan. At the same time, the purchase policy contains a broader clause reserving discretion to treat fees collected for involved parties as nonrefundable. Request written confirmation of how the explicit clinical-denial promise governs your selection. The billing checklist can record the amount paid, the provider decision and any separate test charge. It is reasonable to ask for reconciliation before checkout rather than assuming either the broad clause or the favorable product summary always controls. A clear answer should identify the charge to be returned, any exception and the refund process. Save that answer with the selected plan confirmation so the financial outcome can be assessed against the agreement actually offered to you.
The purchase policy describes a different boundary once consultation is completed and a prescription is issued and transmitted for pharmacy fulfillment. At that stage it treats the order as final and nonrefundable regardless of shipment status. Later renewal periods are also described as nonrefundable after the charge occurs. Some therapies carry minimum commitments, with fees continuing through the active commitment even if shipments are stopped. Ask whether and how that provision applies to the selected weight-care plan. A cancel-anytime statement can stop future renewal without reversing money already owed. If you want to leave, obtain written confirmation of both the current pharmacy order and the next subscription charge. The provider comparison worksheet can include these exit conditions alongside the plan's inclusions. The policy also describes possible reprocessing charges for prescription changes after pharmacy submission and for certain shipping-address errors. Confirm the actual order information before submission. Those commercial details are separate from a clinician's advice to modify treatment and should never become a reason to continue an unsuitable prescription merely to preserve a paid package.
The final questions concern the actual dispenser and continuing medical review. PrescribedRX describes independent licensed professionals and pharmacy fulfillment, while the public materials do not establish the individual facility assigned to your order. Use the pharmacy checking guide to obtain its identity, location and relevant current license. Portal messaging is an access feature; ask how clinical concerns are handled, when planned reassessment occurs and whether another review is needed before a renewal prescription. A laboratory test may be ordered when the history calls for it, so establish who pays if that becomes necessary. Compounded medicines are not FDA-approved, and branded-product trial results do not establish the outcome of the exact preparation offered here. The compounded semaglutide evidence discussion can support that conversation. PrescribedRX may fit someone who wants a clearly described quarterly care purchase and understands that payment precedes approval. Its unresolved checks are the binding clinical-denial refund agreement, complete selected financial scope, actual dispensing assignment and continuing-care requirements. Resolve those before comparing the monthly equivalent with an unrestricted month-to-month service.
What PrescribedRX costs
A current standing monthly total is not established here. Request a written product-specific quote from PrescribedRX.
Also offered; confirm the complete product-specific quote: Compounded semaglutide (injection), Compounded tirzepatide (injection).
Want PrescribedRX's current price for your dose?
Your monthly price is the same through our link.
What signing up looks like
Review the complete quarterly plan
Confirm the prescribed product, included services, taxes, commitment and next charge.
Submit eligibility information and payment
The product pages describe checkout before the licensed provider makes the treatment decision.
Confirm approval or refund outcome
Reconcile the explicit denial promise with the broader purchase-policy clause.
Track pharmacy and renewal events
Identify the dispensing facility and know when an order or renewed billing period becomes final.
Who prescribes, and the pharmacy
PrescribedRX describes independent licensed professionals through a third-party medical group and separate pharmacy fulfillment. A named care team does not establish the assigned prescriber or pharmacy; the actual facility and relevant current license remain to be confirmed.
Where PrescribedRX does well
- Individual GLP-1 pages state the three-month payment interval.
- The product pages identify compounded injections and listed inclusions.
- The clinical-denial refund promise expressly addresses program-fee deductions.
- The platform distinguishes its administrative role from clinical and dispensing services.
What to check first
- Quarterly payment is larger than a monthly equivalent. Compare the full commitment.
- A broad discretionary nonrefund clause coexists with the denial promise. Request reconciliation.
- Prescription transmission can make an unshipped order final. Confirm the status.
- Stopping shipments may not end an active commitment. Obtain the selected exit agreement.
It fits you if
You can evaluate a quarterly medication-and-care purchase and want to understand payment before approval and the written denial-refund terms.
Look elsewhere if
You need to buy one unrestricted month at the displayed equivalent or want cancellation to reverse an already submitted prescription.
Three more providers to weigh
Ro
Price after intake
Found
PartnerFrom $314/mo
Sesame
PartnerPrice after intake
Questions about PrescribedRX
- Are the GLP-1 plans billed monthly?
- The current individual pages describe charges every three months and display a monthly equivalent. The equivalent is not a standalone one-month purchase.
- When is payment taken?
- The weight-care pages describe payment after eligibility questions and before the provider completes clinical review.
- Is there a full refund if treatment is declined?
- The product and purchase pages explicitly promise a full treatment-program refund without fee deductions, excluding the hormone lab panel. Ask how that promise applies alongside the broader discretionary nonrefund clause.
- Can I cancel an unshipped approved order?
- The purchase policy treats an order as final after consultation, prescription issuance and pharmacy transmission, regardless of shipment status.
- Are laboratories always required for weight care?
- The product pages say the provider orders them when the history calls for it. Confirm any individual testing requirement and its cost.
Still weighing PrescribedRX?
Where this review comes from
- PrescribedRX website, treatment information and published policies
- Understanding the risks of compounded drugs (October 26, 2026)